Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Globulins are a group of proteins in blood plasma that include immunoglobulins (antibodies), which play a crucial role in immune defense. In the context of blood poisoning, or sepsis, the administration of intravenous immunoglobulins (IVIG)—a preparation of pooled immunoglobulins derived from healthy donors—has been studied and used to support the immune response against overwhelming infection. The rationale is that IVIG can provide passive immunity, neutralize toxins, and modulate the immune system to help combat severe bacterial infections that lead to sepsis.

Evidence supporting this use comes from several clinical studies and meta-analyses. Some trials have shown that adjunctive IVIG therapy can reduce mortality in certain subgroups of septic patients, particularly those with toxic shock syndrome or specific deficiencies in antibody production. However, large randomized controlled trials have produced mixed results, leading to ongoing debate about the routine use of IVIG in all septic patients. Major clinical guidelines, such as those from the Surviving Sepsis Campaign, currently do not recommend routine IVIG use due to insufficient evidence of overall benefit, but acknowledge its potential in selected cases.

In summary, while globulins—specifically IVIG—have a scientifically validated role in the management of blood poisoning in certain contexts, the strength of evidence varies depending on patient population and clinical scenario. The overall evidence level is moderate, reflecting both promising results in specific cases and inconclusive findings in broader sepsis populations.

More about Globulins
More about Blood Poisoning

Other ingredients used for Blood Poisoning

Other health conditions supported by Globulins

Products containing Globulins